GROVE COLLABORATIVE HOLDINGS (GROV)

US39957D2018 - Common Stock

1.62  -0.02 (-1.22%)

After market: 1.57 -0.05 (-3.09%)

Fundamental Rating

2

GROV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 126 industry peers in the Specialty Retail industry. GROV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GROV is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

GROV had negative earnings in the past year.
In the past year GROV has reported a negative cash flow from operations.
In the past 5 years GROV always reported negative net income.
GROV had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of GROV (-29.53%) is worse than 91.27% of its industry peers.
GROV has a worse Return On Equity (-245.65%) than 80.95% of its industry peers.
Industry RankSector Rank
ROA -29.53%
ROE -245.65%
ROIC N/A
ROA(3y)-51.45%
ROA(5y)N/A
ROE(3y)-335.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 52.96%, GROV belongs to the top of the industry, outperforming 84.92% of the companies in the same industry.
In the last couple of years the Gross Margin of GROV has grown nicely.
The Profit Margin and Operating Margin are not available for GROV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.12%
GM growth 5Y8.83%

4

2. Health

2.1 Basic Checks

GROV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GROV has less shares outstanding
The debt/assets ratio for GROV is higher compared to a year ago.

2.2 Solvency

GROV has an Altman-Z score of -3.83. This is a bad value and indicates that GROV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.83, GROV is doing worse than 82.54% of the companies in the same industry.
GROV has a Debt/Equity ratio of 3.95. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 3.95, GROV is doing worse than 78.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.95
Debt/FCF N/A
Altman-Z -3.83
ROIC/WACCN/A
WACC8.26%

2.3 Liquidity

GROV has a Current Ratio of 3.54. This indicates that GROV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.54, GROV belongs to the top of the industry, outperforming 96.03% of the companies in the same industry.
GROV has a Quick Ratio of 2.72. This indicates that GROV is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of GROV (2.72) is better than 96.83% of its industry peers.
Industry RankSector Rank
Current Ratio 3.54
Quick Ratio 2.72

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.27% over the past year.
The Revenue for GROV has decreased by -19.33% in the past year. This is quite bad
GROV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.84% yearly.
EPS 1Y (TTM)50.27%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-8%
Revenue 1Y (TTM)-19.33%
Revenue growth 3Y-10.72%
Revenue growth 5Y19.84%
Revenue growth Q2Q-19.11%

3.2 Future

GROV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.90% yearly.
GROV is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.08% yearly.
EPS Next Y52.14%
EPS Next 2Y38.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.59%
Revenue Next 2Y-5.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

GROV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GROV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as GROV's earnings are expected to grow with 38.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.9%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

GROV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GROVE COLLABORATIVE HOLDINGS

NYSE:GROV (4/23/2024, 3:10:02 PM)

After market: 1.57 -0.05 (-3.09%)

1.62

-0.02 (-1.22%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap61.85M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.53%
ROE -245.65%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 52.96%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 3.95
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.54
Quick Ratio 2.72
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)50.27%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y52.14%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-19.33%
Revenue growth 3Y-10.72%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y